Diabetes

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC9712	Iinerixibat	GSK2330672 is a highly potent, nonabsorbable ASBT(apical sodium-dependent bile acid transporter) inhibitor (hASBT IC50=42 ± 3 nM) .
DCAPI1506	Mitiglinide Calcium	Inhibitor of ATP-sensitive K+ channel activity in MIN 6 cells. Has also been shown to bind sulfonylurea receptors as well.
DCAPI1573	Ipragliflozin (ASP1941) Featured	Ipragliflozin (ASP1941) is a Novel Selective Sodium-Dependent Glucose Co-Transporter 2 Inhibitor, on Urinary Glucose Excretion in Healthy Subjects
DC11190	JTT-551	JTT-551 (JTT551, JTT 551) is a novel potent, selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) with Ki of 0.22 uM, displays >45-fold and >136-fold selectivity over TCPTP, CD45 and LAR.
DC11191	JTT-551 sodium	JTT-551 sodium (JTT551, JTT 551) is a novel potent, selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) with Ki of 0.22 uM, displays >45-fold and >136-fold selectivity over TCPTP, CD45 and LAR.
DC10278	LGD-6972 Featured	LGD-6972 is a selective and orally active glucagon receptor antagonist. LGD-6972 has the potential for type 2 diabetes research.
DC1105	Linagliptin (BI-1356) Featured	Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM.
DC10765	LX-2761	LX2761 is a locally acting SGLT1 inhibitor that is highly potent in vitro and delays intestinal glucose absorption in vivo to improve glycemic control.
DC7921	Sotagliflozin (LX-4211) Featured	LX-4211 is a potent dual SGLT2/1 inhibitor; Antidiabetic agents.
DC11681	LY2922470	LY2922470 (LY-2922470) is a potent, selective, orally available GPR40 agonist with EC50 of 7 nM.
DC8041	MK-0941 Featured	MK-0941 is a novel Glucokinase activator (GKA)
DC7585	Omarigliptin Featured	MK-3102 (MSD) is a novel DPP-4 Inhibitor, which improves glycaemic control with low risk of symptomatic hypoglycaemia.
DC5034	MK8245 Featured	MK-8245 is an liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy.
DC12020	MK-8722 Featured	MK-8722 is a systemic, Direct Pan-Activator of AMP-Activated Protein Kinase.
DC10807	O304 Featured	O304 is a novel AMPK activator.
DC7227	PF-04620110 Featured	PF-04620110 is an orally active, selective and potent diglyceride acyltransferase-1 (DGAT1) inhibitor with IC50 of 19 nM.
DC3108	PF-04971729 (Ertugliflozin) Featured	PF-04971729 is a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2, is currently in phase 2 trials for the treatment of diabetes mellitus.
DC10050	PF05175157 Featured	PF-05175157 is a potent and selective inhibitor of both acetyl-CoA carboxylase isoform ACC1 located primarily in liver and adipose tissue and isoform ACC2 dominant in skeletal and heart muscle, with IC50 values of 27 nM and 33 nM, respectively.
DC11466	PF-06409577 Featured	PF-06409577 is a potent and selective allosteric activator of AMPK α1β1γ1 isoform with an EC50 of 7 nM.
DC9454	Ro 28-1675	Ro 28-1675 (Ro 0281675) is a potent allosteric GK activator with a SC1.5 value of 0.24± 0.0019 uM.
DC9084	Rosiglitazone base	Rosiglitazone(BRL-49653) is a high-affinity selective agonist of the peroxisome proliferator-activated receptor-γ(PPARγ).
DC8875	Saxagliptin Featured	Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM and Ki of 1.3 nM.
DC9690	Sinogliatin (HMS5552, RO5305552) Featured	Sinogliatin (HMS5552, RO5305552) is a mall molecule glucokinase (GCK; GK) activator.
DC10581	Succinobucol（AGI 1067) Featured	Succinobucol is a phenolic antioxidant with anti-inflammatory and antiplatelet effects.
DC5073	TAK-875(Fasiglifam) Featured	TAK-875 is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 0.072 μM.
DC7515	Teglicar Featured	Teglicar, in vitro and in animal models, reduces gluconeogenesis and improves glucose homeostasis, refreshing the interest in selective and reversible L-CPT1 inhibition as a potential antihyperglycemic approach.
DC7826	Tofogliflozin hydrate	Tofogliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2).
DC8903	Troglitazone	Troglitazone(CS-045), PPARγ agonist, is an anti-diabetic thiazolidinedione (TZD) with anti-inflammatory and anti-tumor activity.
DC9343	ZLN024 (hydrochloride)	ZLN024 Hcl is a novel AMPK allosteric activator; activated α1β1γ1 and α2β1γ1 by around 2–2.5 fold with an EC50 of about 1–2 uM. IC50 value: 1-2 uM (EC50) [1] Target: AMPK activator ZLN024 activated AMPK in L6 myotubes and stimulated glucose uptake and
DC10320	Saroglitazar (Magnesium)	Saroglitazar magnesium is a novel peroxisome proliferator-activated receptor (PPAR) agonist with predominant PPARα and moderate PPARγ activity with EC50 values of 0.65 pM and 3 nM in HepG2 cells, respectively.

Diabetes

Customized Consultation X

Your information is safe with us. * Required Fields.